Literature DB >> 1562235

A monoclonal antibody which recognizes cell surface antigen and inhibits porcine parvovirus replication.

M J Harding1, T W Molitor.   

Abstract

Monoclonal antibody technologies were applied to the study of early events in porcine parvovirus (PPV) infections in vitro. Balb/c mice were immunized with whole swine testicle cells and hybridomas were produced following fusion with myeloma cells. Resultant clones were screened firstly in an ELISA system, to detect monoclonal antibody recognition of swine testicle cells, and secondly, in a fluorescent antibody test to detect monoclonal antibody which inhibited production of PPV antigen. One clone, 1H11, which satisfied these screening requirements, recognized proteins present in cell lines both permissive and non-permissive for porcine parvovirus replication and inhibited the production of virus progeny of several PPV isolates. A linear staining pattern of cross-linked plasma membranes, indicative of monoclonal antibody binding at the cell membrane, was demonstrated by indirect immunofluorescence assays. In immunoblotting experiments, 1H11 recognized a polypeptide of approximately 40 kDa in size, present in both permissive and non-permissive cell lines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562235     DOI: 10.1007/bf01317267

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Replication of the parvovirus MVM. I. Dependence of virus multiplication and plaque formation on cell growth.

Authors:  P Tattersall
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

4.  Parvoiruses as contaminants of permanent human cell lines. I. Virus isolation from 1960-1970.

Authors:  C Hallauer; G Kronauer; G Siegl
Journal:  Arch Gesamte Virusforsch       Date:  1971

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Pathogenesis of in utero infection: experimental infection of five-week-old porcine fetuses with porcine parvovirus.

Authors:  W L Mengeling; R C Cutlip
Journal:  Am J Vet Res       Date:  1975-08       Impact factor: 1.156

7.  Oronasal and intramuscular vaccination of swine with a modified live porcine parvovirus vaccine: multiplication and transmission of the vaccine virus.

Authors:  P S Paul; W L Mengeling
Journal:  Am J Vet Res       Date:  1984-12       Impact factor: 1.156

8.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  Biological assay of attenuated strain NADL-2 and virulent strain NADL-8 of porcine parvovirus.

Authors:  W L Mengeling; Z Pejsak; P S Paul
Journal:  Am J Vet Res       Date:  1984-11       Impact factor: 1.156

10.  KBSH parvovirus: comparison with porcine parvovirus.

Authors:  T W Molitor; H S Joo; M S Collett
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more
  2 in total

1.  Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus.

Authors:  Maude Boisvert; Sandra Fernandes; Peter Tijssen
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

2.  Identification of bovine viral diarrhea virus receptor in different cell types.

Authors:  W Xue; H C Minocha
Journal:  Vet Microbiol       Date:  1996-03       Impact factor: 3.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.